The probable reason may be that PD-L1 has a dual channel blocking effect of PD-1/PD-L1 and PD-1/CD80 pathway, which can overcome the problem of low PD-L1 expression in SCLC tumour cells. Here, PDCD1 is linked to small cell lung carcinoma.